Expert Commentary

Acute heart failure: What works, what doesn’t

Publish date: February 11, 2016

 

EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS

References

Dr. Desai reported receiving research funding from Novartis and St. Jude Medical and serving as a paid consultant to Merck, Relypsa, and St. Jude Medical.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Primary care endures in heart failure management
MDedge Cardiology
Families perceive few benefits from aggressive end-of-life care
MDedge Cardiology
David Bowie’s death inspires blog on palliative care
MDedge Cardiology
Neurosurgeon memoir illuminates the journey through cancer treatment and acceptance of mortality
MDedge Cardiology
Finding more transplant hearts but not more donors
MDedge Cardiology
Hypertrophic cardiomyopathy: Who should get an ICD?
MDedge Cardiology
STS: Score stratifies risks for isolated tricuspid valve surgery patients
MDedge Cardiology
How to use two new game-changing heart failure drugs
MDedge Cardiology
MI, heart failure mortality rates slightly lower in VA hospitals
MDedge Cardiology
STS: Risk score predicts rehospitalization after heart surgery
MDedge Cardiology